← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Virscio, Inc.
Hamden, CT
$5,723,094
Total funding
8
Grants
Funding over time
peak $1.1M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,723,094 · 8
By mechanism
R44$4,043,855 · 3
R43$1,679,239 · 5
Investigators at Virscio, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates$1,119,343
R44 · FY2020 · AG
Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates$770,793
R44 · FY2021 · AG
Toxicogenomics of Hepatotoxicity in Monkeys$736,277
R44 · FY2006 · DK
Silencing cardiac-specific microRNAs to prevent pathological remodeling in conges$718,304
R43 · FY2011 · HL
Ultrasound-Mediated Blood-Brain Barrier Permeabilization in Primates$694,061
R44 · FY2008 · NS
Ultrasound-Mediated Blood-Brain Barrier Permeabilization in Primates$668,381
R44 · FY2009 · NS
Primate epigenetic and senescence biomarkers to advance aging science and anti-aging strategies.$291,913
R43 · FY2025 · AG
Ultrasound-Mediated Blood-Brain Barrier Permeabilization in Primates$208,554
R43 · FY2006 · NS
Amyloid Beta Oligomer Induction of Alzheimer's Disease in Nonhuman Primates$208,412
R43 · FY2017 · OD
Establishing a neuroprotection model in the nonhuman primate to support translati$203,038
R43 · FY2013 · EY
Toxicogenomics of Hepatotoxicity in Monkeys$55,000
R44 · FY2006 · DK
Amyloid Beta Oligomer Induction of Alzheimer's Disease in Nonhuman Primates$49,018
R43 · FY2018 · OD